OMNIAB, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 4.73K shares.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 11.98K shares, a 98.03% decline from fiscal 2024.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 607.59K shares, a 274.98% increase from fiscal 2023.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 162.03K shares.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 4.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 4.73K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 11.98K shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 147.54K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 177.40K shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 11.98K shares 10-Q · filed 2025-05-08 | 349.90K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 135.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 607.59K shares 10-K · filed 2025-03-18 |
| 2024-09-30 | 29.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 530.64K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 172.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 553.46K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 269.67K shares 10-Q · filed 2024-05-09 | 431.70K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 58.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 162.03K shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 52.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2023-06-30 | 50.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 0.00 shares 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |